Tubidy
    Melody Chang, RPh, shares how 340B is affecting pharmacy operations at Florida Cancer Specialists

    Melody Chang, RPh, shares how 340B is affecting pharmacy operations at Florida Cancer Specialists

    01:23 |
    Download MP3

    Related Videos

    Charles Rudin, MD, PhD, shares the take home message regarding Keynote-604 for lung cancer treatment 0:46

    Charles Rudin, MD, PhD, shares the take home message regarding Keynote-604 for lung cancer treatment

    Next-Gen Sequencing is Transforming Oncology Practices 4:27

    Next-Gen Sequencing is Transforming Oncology Practices

    Charles Loprinzi, MD, explains the role of palliative and supportive care in medical oncology 2:41

    Charles Loprinzi, MD, explains the role of palliative and supportive care in medical oncology

    Edward Kim, MD, describes how immunotherapy combinations will be used in the near future 1:36

    Edward Kim, MD, describes how immunotherapy combinations will be used in the near future

    William K. Oh, MD, considers the role of PARP inhibitors in mCRPC 2:37

    William K. Oh, MD, considers the role of PARP inhibitors in mCRPC

    Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists 2:19

    Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists

    Kim N. Chi, MD, on what findings from the Phase III TITAN study mean for patients 0:58

    Kim N. Chi, MD, on what findings from the Phase III TITAN study mean for patients

    Debu Tripathy, MD, on the use of hormonal therapy in the PALOMA-2 clinical study 0:41

    Debu Tripathy, MD, on the use of hormonal therapy in the PALOMA-2 clinical study

    Daniel M. Geynisman, MD, on how real-world analysis influences clinical decision-making 2:20

    Daniel M. Geynisman, MD, on how real-world analysis influences clinical decision-making

    Debra Patt, MD, PhD, MBA, on the promising investigations of CDK4/6 inhibitors 0:54

    Debra Patt, MD, PhD, MBA, on the promising investigations of CDK4/6 inhibitors

    Alexander Spira, MD, PhD, FACP, on managing lung cancer patients in a community setting 0:50

    Alexander Spira, MD, PhD, FACP, on managing lung cancer patients in a community setting

    Jeff Vacirca, MD, explains why OneOncology is a unique practice model 0:52

    Jeff Vacirca, MD, explains why OneOncology is a unique practice model

    Bo Gamble, compares and contrasts the definition of value and quality as it relates to cancer care 1:59

    Bo Gamble, compares and contrasts the definition of value and quality as it relates to cancer care

    Will NGS-Based Cancer Tests Become Routine? 3:23

    Will NGS-Based Cancer Tests Become Routine?

    Christopher J. Kane MD, FACS, on trends in the multimodality treatment of localized prostate cancer 2:55

    Christopher J. Kane MD, FACS, on trends in the multimodality treatment of localized prostate cancer

    The impact of clinical pathways on quality cancer care as explained by Bruce Gould, MD 0:37

    The impact of clinical pathways on quality cancer care as explained by Bruce Gould, MD

    Erika Hamilton, MD, on how CDK4/6 inhibitors transformed the management of metastatic breast cancer 1:12

    Erika Hamilton, MD, on how CDK4/6 inhibitors transformed the management of metastatic breast cancer

    Russell Gollard, MD, explains how IDNs effectively coordinate cancer care 1:44

    Russell Gollard, MD, explains how IDNs effectively coordinate cancer care

    Dana Chase, MD, shares details about PRIMA and PAOLA clinical studies regarding ovarian cancer 5:14

    Dana Chase, MD, shares details about PRIMA and PAOLA clinical studies regarding ovarian cancer

    Hani Babiker, MD, describes the setting of FDA approval on tumor treatment fields 0:19

    Hani Babiker, MD, describes the setting of FDA approval on tumor treatment fields